Radicava (Edaravone)

Radicava is a newly FDA-approved intravenously administered free radical scavenger for the treatment of amyotrophic lateral sclerosis (ALS). Oxidative stress has been considered to be involved in the onset and progression of ALS; it’s postulated that elimination of...